Rheumatology professional and patients visited with 117 legislators and their staffs during the 2019 Advocates for Arthritis event to champion better rheumatology patient care and access.
RheumPAC Advocates for Dept. of Defense Arthritis Research Funding
RheumPAC is the ACR’s non-partisan political action committee, which promotes the needs of rheumatology providers and patients. Advocacy efforts often focus on legislation to improve the day-to-day clinical care of rheumatology patients, such as establishing clinical exceptions to step therapy requirements and reforming the prior authorization process. In addition, the ACR and RheumPAC recognize the…
Patients & Physicians Unite for Arthritis Advocacy
Nearly 120 ACR/ARP member advocates and rheumatology patients were on Capitol Hill this week fighting for rheumatology as part of the ACR’s Advocates for Arthritis conference.
CMS Proposes Major Payment Increases for E/M Services
CMS estimates that under their proposal, released July 29, rheumatologists would see on average a 15% payment increase, beginning in 2021.
RheumPAC Advocates for Department of Defense Arthritis Research Funding
The ACR’s nonpartisan political action committee is continuing to advocate for increased defense department funding for rheumatology research. Learn about RheumPAC’s efforts and how you can help.
The ACR & ARP Fight Step Therapy on Capitol Hill
Step therapy (or fail first) policies introduce significant barriers to access to effective treatments for patients with rheumatic diseases. They also impose significant administrative and cost burdens on providers and practices. The ACR and ARP are advocating state governments, Congress and regulatory agencies limit the impact of these policies on access to care by creating…
ACR Volunteer Leaders Visit Capitol Hill, Lobby for 5 Issues
WASHINGTON, D.C.—Dozens of rheumatology leaders met with more than 100 politicos on Capitol Hill in mid-May as part of the ACR’s annual Advocacy Leadership Conference. Armed with research and advocacy training concerning a handful of important issues, rheumatologists, rheumatology interprofessional team members, government affairs specialists and others met with federal lawmakers, legislative aides and correspondents….
Access 2020 Campaign Update
We are nearing the halfway point of 2019 and are one-quarter of the way through the ACR’s recently launched Access 2020 campaign, an advocacy campaign to increase ACR/ARP access to decision makers and the rulemaking process through RheumPAC by raising $300,000 and increasing the number of ACR/ARP members who contribute to 900. Progress Report So…
Advocacy Leads to Legislator Access
We have often heard it said that opportunity arises from challenges. Challenge, of course, is really just a polite way of saying problem—and for our patients, problems abound when it comes to obtaining timely and affordable access to the rheumatologic care they need. Access in this context has many meanings: There is access to life-changing…
Advocacy Up Close: Dr. Gary Bryant Discusses the Role & Benefits of RheumPAC
RheumPAC, the ACR’s political action committee (PAC), is tasked with fundraising, vetting legislators, participating in Capitol Hill visits and developing important relationships for the College. During my interview with Gary Bryant, MD, the ACR’s inaugural RheumPAC chair, he shared his thoughts on the role of rheumatology advocacy in advancing clinical practice, research and education. ACR@Work: Have…
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 12
- Next Page »